PENTAVALENT Bio Sciences' Grant

PENTAVALENT Bio Sciences raised a round of funding on May 09, 2017. Investors include Idea2PoC.

PENTAVALENT Bio Sciences is developing a precise, rapid, and ultrasensitive DNA cassette-based tool for antibiotic profiling of mycobacterium tuberculosis and treatment decision for tuberculosis patie…

Articles about PENTAVALENT Bio Sciences' Grant: